Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.52897 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44137 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44509 | 18 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.37907 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39882 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.55466 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.4413 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.42501 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.39193 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.42015 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.42628 | 18 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.40834 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43159 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43242 | 18 |